Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting - Trial NCT04900844
Access comprehensive clinical trial information for NCT04900844 through Pure Global AI's free database. This phase not specified trial is sponsored by InspireMD and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 315 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
InspireMD
Timeline & Enrollment
N/A
Jul 01, 2021
Oct 01, 2025
Primary Outcome
Composite of DSMI through 30 days or ipsilateral stroke 31 - 365 days post-index procedure
Summary
The objective of this pivotal study is to evaluate the safety and efficacy of the CGuard™
 Carotid Stent System in the treatment of carotid artery stenosis in symptomatic and
 asymptomatic patients undergoing carotid artery stenting (CAS) to a performance goal
 developed from published CAS literature.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04900844
Device Trial

